unknown
Stage
About
GlyTR Therapeutics is a biotech company developing a new class of anti-cancer immunotherapeutic molecules and CAR-T cell therapies that target multiple types of cancer antigens across solid and blood cancers.
Explore GlyTR Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.